Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.65 |
| ▸ | HTT | P42858 | 4/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.63 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | MITF | O75030 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | XBP1 | P17861 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.56 |
| ▸ | TGM2 | P21980 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.55 |
| ▸ | NAMPT | P43490 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4-Nitroaniline SCHEMBL3978656 | 0.92 | ALDH1A1 (0.56) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL23748585 | 0.91 | MEN1 (0.70) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL10923174 | 0.91 | NPSR1 (0.73) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL6407959 | 0.88 | MEN1 (0.59) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL9018657 | 0.87 | MEN1 (0.71) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL1429699 | 0.86 | MEN1 (0.65) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL5118037 | 0.84 | HTT (0.51) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL7741358 | 0.84 | MEN1 (0.67) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL4746770 | 0.83 | MEN1 (0.63) | MEN1KMT2AHTTMAPTALDH1A1 | |
| SCHEMBL9081388 | 0.82 | NPC1 (0.76) | MEN1KMT2AHTTMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 140 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111004141-B | New method for synthesizing nintedanib intermediate 2-chloro-N-methyl-N- (4-nitrophenyl) acetamide | 苏州诚和医药化学有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-111004141-A | Novel method for synthesizing Nintedanib intermediate 2-chloro-N-methyl-N- (4-nitrophenyl) acetamide | 苏州诚和医药化学有限公司 | 2020-04-14 | — | — | CN | claimed |
| CN-101638391-A | 2-[(substituted aminobenzene)carbonylmethylthio]-6-(2,6-dichlorobenzyl)-3H-pyrimidyl-4-ketone derivative and preparation method and application thereof | UNIV SHANDONG | 2010-02-03 | — | — | CN | claimed |
| WO-2025215121-A1 | HEDGEHOG ACYLTRANSFERASE INHIBITORS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2025-10-16 | — | — | WO | disclosed |
| EP-4622986-A1 | BORONIC ACID AND BORONATE COMPOSITIONS AND METHODS | Elima Therapeutics, Inc. (US) | 2025-10-01 | — | — | EP | disclosed |
| US-12214338-B1 | Acid treatment method for making organoselenium composite | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2025-02-04 | — | — | US | disclosed |
| US-12179185-B1 | Method of treating palm waste to form organoselenium nanocomposite | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2024-12-31 | — | — | US | disclosed |
| US-12115524-B1 | Method of producing organoselenium-based nanocomposite | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2024-10-15 | — | — | US | disclosed |
| CN-118496218-A | Carbazole-oxadiazole alpha-glucosidase and alpha-amylase double-target inhibitor and preparation method and application thereof | 贵州医科大学 | 2024-08-16 | — | — | CN | disclosed |
| CN-118126030-A | Preparation method of pyrazoline-1, 3, 4-oxadiazole thioacetamide derivative and application of pyrazoline-1, 3, 4-oxadiazole thioacetamide derivative as pesticide | 贵州大学 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024112705-A1 | BORONIC ACID AND BORONATE COMPOSITIONS AND METHODS | ELIMA THERAPEUTICS, INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| US-4251657-A | Method for removing protective groups | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-02-17 | — | — | US | disclosed |
| US-4206144-A | N,N-Dialkyl-N-aminoalkyl-N-(amino or nitro)phenylalkyl- and N-methyl-N-[3-(amino or nitro)phenoxy-2-hydroxy-1-propyl]-N,N-bis(3-aminopropyl)quaternary ammonium salts | STERLING DRUG INC. (US) | 1980-06-03 | — | — | US | disclosed |
| EP-0006722-A1 | Derivatives of (4-(piperazin-1-yl-phenyloxymethyl)-1.3-dioxolan-2-ylmethyl)-1H-imidazoles and -1H-1.2.4-triazoles, their preparation and use as fungicides and bactericides | JANSSEN PHARMACEUTICA N.V. (BE) | 1980-01-09 | — | — | EP | disclosed |
| US-4146558-A | Azo dyestuff intermediate nitro- or aminobenzenes ring-substituted by a quaternized amine alkyl or amino-alkoxy group | STERLING DRUG INC. (US) | 1979-03-27 | — | — | US | disclosed |
| US-4103092-A | Water-soluble quaternary ammonium non-heterocyclic azo dyestuffs | STERLING DRUG INC. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4102924-A | REACTING ACYLAMINO-ARYLS WITH HALO-ARYLS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-07-25 | — | — | US | disclosed |
| US-4065500-A | Water-soluble quaternary ammonium azo dyestuffs | STERLING DRUG INC. (US) | 1977-12-27 | — | — | US | disclosed |
| US-3996282-A | Water-soluble quaternary ammonium dyestuffs | STERLING DRUG INC. (US) | 1976-12-07 | — | — | US | disclosed |
| US-3935182-A | Water-soluble quaternary ammonium heterocyclic azo dyestuffs | STERLING DRUG INC. (US) | 1976-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12179185-B1 | Method of treating palm waste to form organoselenium nanocomposite | LCAT, PHOSPHO1, SOAT1 | MEN1 2614/4885KMT2A 891/4885HTT 2104/4885 |
| US-12214338-B1 | Acid treatment method for making organoselenium composite | LCAT, PHOSPHO1, AS3MT | MEN1 2171/4885KMT2A 1082/4885HTT 1749/4885 |
| US-12115524-B1 | Method of producing organoselenium-based nanocomposite | LCAT, PHOSPHO1, SOAT1 | MEN1 2149/4885KMT2A 1084/4885HTT 2230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.